Last reviewed · How we verify
Placebo of Venitol Tab. — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of Venitol Tab. (Placebo of Venitol Tab.) — Hanlim Pharm. Co., Ltd.. This is a placebo formulation with no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of Venitol Tab. TARGET | Placebo of Venitol Tab. | Hanlim Pharm. Co., Ltd. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of Venitol Tab. CI watch — RSS
- Placebo of Venitol Tab. CI watch — Atom
- Placebo of Venitol Tab. CI watch — JSON
- Placebo of Venitol Tab. alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of Venitol Tab. — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-venitol-tab. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab